Braun Hillary J, Wasterlain Amy S, Dragoo Jason L
*Department of Orthopaedic Surgery, Stanford University, Redwood City †School of Medicine, University of California, San Francisco, San Francisco, CA.
Sports Med Arthrosc Rev. 2013 Dec;21(4):206-12. doi: 10.1097/JSA.0000000000000005.
Platelet-rich plasma (PRP) has become a popular treatment for acute and chronic soft tissue injuries. Although the majority of research has focused on its use in tendinopathy, PRP may have potential in meniscus and ligament healing. Some level II studies support a possible benefit for anterior cruciate ligament (ACL) allograft maturation, and preliminary animal studies point to a potential role for PRP in primary ACL repair. However, randomized controlled trials have not demonstrated a benefit of PRP for ACL tendon allograft-tunnel integration. To date, 2 studies document the use of PRP for meniscal applications, but this field is largely unexplored. With respect to ligament and meniscal applications, the current literature suggests PRP may be promising for primary ACL repair in skeletally immature patients, ACL graft maturation, and repair of meniscal tears in the avascular zone.
富血小板血浆(PRP)已成为治疗急慢性软组织损伤的常用方法。尽管大多数研究集中在其在肌腱病中的应用,但PRP在半月板和韧带愈合方面可能具有潜力。一些二级研究支持PRP可能对前交叉韧带(ACL)同种异体移植物成熟有益,初步动物研究表明PRP在原发性ACL修复中可能发挥作用。然而,随机对照试验尚未证明PRP对ACL肌腱同种异体移植物与骨隧道整合有益。迄今为止,有2项研究记录了PRP在半月板应用中的使用情况,但该领域在很大程度上尚未得到充分探索。关于韧带和半月板应用,当前文献表明PRP可能有望用于骨骼未成熟患者的原发性ACL修复、ACL移植物成熟以及无血管区半月板撕裂的修复。